Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.
Saved in:
| Title: | Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion. |
|---|---|
| Authors: | Shenderov E; Medical Oncology, Johns Hopkins Medicine-The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Sharma MR; The START Center for Cancer Research-Midwest, Grand Rapids, Michigan, USA., Garralda E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Powderly J; Carolina BioOncology Institute, Huntersville, North Carolina, USA., Ługowska I; Centre of Excellence in Precision Cancer Medicine, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Spira A; Research Institute, Virginia Cancer Specialists, Fairfax, Virginia, USA., Salamero MC; Medical Oncology Department, Institut Català d'Oncologia, Badalona, Spain., Jang S; Hematology and Oncology, Inova Schar Cancer Institute, Fairfax, Virginia, USA., Cosman R; Medical Oncology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia., Shen J; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA., Xu W; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; The University of Queensland, St Lucia, Queensland, Australia., Wysocki PJ; Department of Oncology, Jagiellonian University Medical College Hospital, Krakow, Poland., Ramlau R; Medical Oncology, Poznan University of Medical Sciences, Poznan, Poland., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA., Weickhardt AJ; Medical Oncology Department, Olivia Newton-John Cancer Wellness and Research Centre, Heidelberg, Victoria, Australia., Żołnierek J; Department of Clinical Trials, Szamocka Hospital, Lux Med Oncology, Warsaw, Poland., Calvo E; Early Phase Clinical Trials, START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain., Zhao E; MacroGenics Inc, Rockville, Maryland, USA., Bohac C; MacroGenics Inc, Rockville, Maryland, USA., Ward A; MacroGenics Inc, Rockville, Maryland, USA., Mallesara G; Medical Oncology, Calvary Mater Hospital Newcastle, Waratah, New South Wales, Australia. |
| Source: | Cancer [Cancer] 2026 Aug 01; Vol. 132 (15), pp. e70544. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
